Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Tar Heel Journal.
Press releases published on August 28, 2025
TopQuadrant Hires Data & AI Leader to Drive GTM Launch of AI Copilot for Data Governance Powered by Knowledge Graphs
EIN Presswire
·
August 28, 2025
Ingrid Ramos Nakamura joins TopQuadrant as Head of Marketing to accelerate Go-to-Market growth of AI for data governance, metadata management, and agentic AI RALEIGH, NC, UNITED STATES, August 28, 2025 /EINPresswire.com/ -- TopQuadrant, the leading data …
Quiet Light to Join Elite Ecommerce Accounting Professionals at Camp A2X 2025
EIN Presswire
·
August 28, 2025
The invitation-only event brings together top global firms and industry leaders in Toronto and Stoney Lake, Ontario MOORESVILLE, NC, UNITED STATES, August 28, 2025 /EINPresswire.com/ -- Quiet Light, a leading M…
Cardinal Dermatology Center Welcomes Physician Assistant Mary Candace Seagle, PA-C
EIN Presswire
·
August 28, 2025
Expanded Access to Expert Medical Dermatology and Skin Cancer Care Begins September 17, 2025 CARY, NC, UNITED STATES, August 28, 2025 /EINPresswire.com/ -- Cardinal Dermatology Center, Cary’s trusted medical dermatology practice, is proud to announce …
Ted Edwards recognized in the 2026 Edition of The Best Lawyers in America®
EIN Presswire
·
August 28, 2025
This highlights Mr.Edwards’ leadership of TBLF’s Commercial Litigation Practice …
Food Lion Feeds Rallies for College Hunger Relief
GlobeNewswire
·
August 28, 2025
SALISBURY, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Food Lion Feeds is once again teaming up with college campuses to address food insecurity among students. The annual Sack to Give Back program, now in its sixth year, is part of an ongoing effort to …
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
GlobeNewswire
·
August 28, 2025
CHAPEL HILL, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, …